Bevacizumab May Differentially Improve Prognosis of Advanced Ovarian Cancer Patients with Low Expression of VEGF-A165b, an Antiangiogenic VEGF-A Splice Variant

Wimberger, Pauline; Gerber, Mara Julia; Pfisterer, Jacobus; Erdmann, Kati; Fuessel, Susanne; Link, Theresa; du Bois, Andreas; Kommoss, Stefan; Heitz, Florian; Sehouli, Jalid; Kimmig, Rainer; de Gregorio, Nikolaus; Schmalfeldt, Barbara; Park-Simon, Tjoung-Won; Baumann, Klaus; Hilpert, Felix; Grube, Marcel; Schroder, Willibald; Burges, Alexander; Belau, Antje; Harser, Lars; Kuhlmann, Jan Dominik

Bevacizumab May Differentially Improve Prognosis of Advanced Ovarian Cancer Patients with Low Expression of VEGF-A165b, an Antiangiogenic VEGF-A Splice Variant

Autor(en):

Wimberger, Pauline; Gerber, Mara Julia; Pfisterer, Jacobus; Erdmann, Kati; Fuessel, Susanne; Link, Theresa; du Bois, Andreas; Kommoss, Stefan; Heitz, Florian; Sehouli, Jalid; Kimmig, Rainer; de Gregorio, Nikolaus; Schmalfeldt, Barbara; Park-Simon, Tjoung-Won; Baumann, Klaus; Hilpert, Felix; Grube, Marcel; Schroder, Willibald; Burges, Alexander; Belau, Antje; Harser, Lars; Kuhlmann, Jan Dominik

Tübinger Autor(en):

Kommoss, Stefan
Grube, Marcel

Erschienen in:

Clinical Cancer Research (2022), Bd. 28, H. 21, S. 4660-4668

Verlagsangabe:

Amer Assoc Cancer Research

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1158/1078-0432.CCR-22-1326

ISSN:

1078-0432